https://www.biochainre.com/insights daily 0.75 2022-04-07 https://www.biochainre.com/insights/robust-life-sciences-investment monthly 0.5 2022-04-07 https://www.biochainre.com/insights/medical-breakthroughs monthly 0.5 2022-04-07 https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/a6a5adeb-2094-476c-98c1-210588c50ac7/Asset-2-1.jpeg Insights - Where Medical Breakthroughs are Made - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1252559d-53b4-480f-b529-61c54c359255/Asset-1-1.jpeg Insights - Where Medical Breakthroughs are Made - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/de0a1546-09e8-4329-8da6-0049db3da830/Asset-4-1.jpeg Insights - Where Medical Breakthroughs are Made - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/e792a7d2-f9b4-4f23-89d9-7d1db97f2843/Asset-5-1.jpeg Insights - Where Medical Breakthroughs are Made - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/2309fac3-6cbc-45d3-8719-4d186fa65ada/Asset-3-1.jpeg Insights - Where Medical Breakthroughs are Made - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.biochainre.com/investment-strategy daily 0.75 2022-03-30 https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648619120752-TIFXSPLDPGGLUIAI6HUE/unsplash-image-JdtUKqGdqw8.jpg Investment Strategy https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648619534505-SZE4ZX9EV6YLJ42ZK7H9/unsplash-image-C2DV9RccE_Q.jpg Investment Strategy https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648619678265-WEGYB5PZM149NU79VRW6/unsplash-image-pHSj49gnC0w.jpg Investment Strategy https://www.biochainre.com/home daily 1.0 2025-01-03 https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/6444111e-94c0-40ea-9a10-4b2b4e8213e5/Asset+21.png BioChain https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648162656476-MPSXEBZJDRMY4PFQ4Y4O/Asset+13.png BioChain - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648162656472-ME9FTBE0QBIK3E9YULG7/Asset+12.png BioChain - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648162656481-JGBQGFQNIJI6MOYO45W2/Asset+14.png BioChain - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/940b83c4-873b-4ebb-a30d-38568bd427f4/1.jpg BioChain Assembly Brickyard https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/5a083cef-2443-4d03-8475-e5844b2b7e06/2.jpg BioChain Gateway Innovation Center https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/c9512238-8506-444b-989a-cd90887a4aac/3.jpg BioChain Faraday Avenue https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/e7332b5d-3f30-4fa9-9a7e-3bb16ef878ac/4.jpg BioChain Canton 100 Energy https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/36f4870a-0b5f-4d1d-9605-e5acebd10bfe/5.jpg BioChain Diablo Technology Center https://www.biochainre.com/team daily 0.75 2022-04-19 https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/276430f2-790e-4123-9acb-d5edb6af44d1/Screen+Shot+2017-09-18+at+11.10.08+AM.jpg Team - John Caley PARTNER Mr. Caley has been active in real estate acquisition and redevelopment activities since 1991 and through multiple platforms has overseen directly, or indirectly the acquisition, asset management, development, redevelopment, financing and sale of real properties having combined value of approximately $8.8 billion (including direct acquisition and disposition volume of $2 billion). He has also directly advised and or managed over $2.5 billion of investor equity capital from institutional, private and family office investors on a global basis. Mr. Caley has served in both senior and executive management capacities for companies including: Probitas Partners, Gemini Rosemont, Grubb & Ellis, Rexford Industrial, PM Realty Group and Transwestern. Mr. Caley holds a bachelor’s degree from the University of Arizona with emphasis in political science and history. He is an active member of the Urban Land Institute (ULI), Family Office Association (Resource Council Member) and Association of Foreign Investors in Real Estate (AFIRE). Most notably he was Senior Managing Director with Grubb & Ellis Company and directly oversaw day to day operations of multiple platforms within the investment management subsidiary Grubb & Ellis Equity Advisors, including acquisitions, dispositions, private client management and oversight of $6.2 billion in AUM). https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648162668275-1SHIGQJ1E61Y9JL6KIVU/Christos-Kuliopulos.jpg Team - Christos Kuliopulos PARTNER BOSTON OFFICE Kuliopulos is responsible for the Boston office, development/project management and asset management for Capital Hall Partners. Kuliopulos has over 20 years of real estate advisory and investment experience, including strategic development planning and implementation, capital and partnership structuring, equity raising, real estate investment and commercial due diligence and financial modeling, product positioning and market feasibility, valuation, site selection and acquisition, project management and marketing. He has extensive experience in multiple product types from planned communities, resorts developments, hi-rise buildings, TOD’s, industrial parks, single family home subdivisions, condominium communities, active adult, mill conversions, life sciences, healthcare and senior living. In total, he has been involved in over $5 billion in real estate development, transaction and investment deals throughout the US, Canada, South America and the Caribbean. Kuliopulos has a Masters Degree (Suffolk University) and Business Administration degree (UMASS, Amherst). He has been published and quoted in multiple local and national periodicals on real estate trends. He currently holds his Massachusetts broker license and completed all of the Member of Appraisal Institute courses. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/a326378b-b6fa-4763-a501-bc0af76060d8/JM_color.jpg Team - James Martin ASSET MANAGER James Martin is an Asset Manager with Capital Hall Partners who will also be working with BioChain Real Assets. James has over 20 years of real estate experience with a primary focus on financial analysis, due diligence and valuations. He has provided a variety of real estate advisory services for owners, operators, developers, private investors, REIT’s, and financial institutions. His assignments have included valuations, market and feasibility studies, acquisition due diligence, transaction advisory and asset dispositions. Prior to joining Capital Hall Partners, James was a Senior Director with Kroll and Senior Manager in Ernst & Young’s Transaction Real Estate Services Group. James earned a Masters in Business Administration from Northeastern University, a Bachelors of Engineering from Dartmouth College and a Bachelors of Arts in Physics from Hobart College. He is a Designated Member of the Appraisal Institute and is certified general real estate appraiser. In addition, James is an instructor in the Boston University Real Estate Certificate program where he is the lead instructor for RE175 Argus Cash Flow Modeling and Co-instructor for RE142 Finance, Accounting and Taxation of Real Estate. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648162668269-PV2GJQ4CT9XU7IFDFGYB/bradleyhall-2.jpg Team - Bradley Hall MANAGING PARTNER AND CHIEF EXECUTIVE OFFICER Tobias Keene, D.D.S. Hailing from Richmond, Virginia, Dr. Tobias Keene brings a bit of unabashed Southern hospitality to all his patients. He moved to Washington, D.C. over thirty years ago as a freshman at Ivy College. Right after graduation, he attended World University’s School of Dentistry. Before opening Keene Dental in 1994, he worked for free clinics and some of the finest practices in the District. He is part of the 123 Dental Association and stays up-to-date on the latest dental discoveries. When not striving to keep his patients happy and healthy, he’s enjoys hiking with his family in Rock Creek Park. https://www.biochainre.com/contact daily 0.75 2022-04-23 https://images.squarespace-cdn.com/content/v1/5ce435d6bea1ed00016ba287/1558964652247-5MWXNMFZVOPGE4TY6U2Q/MHeiderich_ReflexionenZwei-05-copy.jpg Contact https://www.biochainre.com/opportunity daily 0.75 2022-04-23 https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648162663977-5GTMS5W19X7JVELABJ25/possessed-photography-iXqcL8iu3vo-unsplash.jpg Opportunity - Value-Driven Investing Our firm selects markets where there is a disconnect between land value and current demand. We specialize on creating profit on the acquisition of the land and being an early mover in our given markets. We then pass profitability to our partners through a detailed and collaborative development process; delivering to the market the most advanced and adaptable buildings in the industry. https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648162663972-RTZY6HNDAUVFKNMT8GZV/jan-kopriva-EXWhFRxYlj8-unsplash.jpg Opportunity - Unprecedented Demand Once-unfathomable breakthroughs in genome sequencing have fundamentally altered the trajectory of the Life Sciences industry, while also changing the course of human history in the process. The commercialization of DNA sequencing and genetic-based therapies have created increased demand for research and development (R&D), laboratory, and bio-manufacturing space. The United States is actively onshoring all of this work, intensifying the need for Life Sciences real estate in the process. BioChain Real Assets is actively working to make space for this innovation. https://images.squarespace-cdn.com/content/v1/5ce435d6bea1ed00016ba287/1558964652247-5MWXNMFZVOPGE4TY6U2Q/MHeiderich_ReflexionenZwei-05-copy.jpg Opportunity https://www.biochainre.com/real-assets daily 0.75 2023-03-15 https://images.squarespace-cdn.com/content/v1/623cf7574867b9004a0aa550/1648162649031-8ZDT46XGH8KQJ216A08I/biochain_spin_blue.gif Real Assets - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.biochainre.com/real-assets/assembly-brickyard monthly 0.5 2022-04-06 https://www.biochainre.com/real-assets/gateway-innovation-center monthly 0.5 2022-04-06 https://www.biochainre.com/real-assets/diablo-technology-center monthly 0.5 2022-04-06 https://www.biochainre.com/real-assets/faraday-avenue monthly 0.5 2022-04-06 https://www.biochainre.com/real-assets/canton-100-energy monthly 0.5 2022-04-06